IL-1 beta Antikörper (AA 114-266) (FITC)
Kurzübersicht für IL-1 beta Antikörper (AA 114-266) (FITC) (ABIN1992843)
Target
Alle IL-1 beta (IL1B) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 114-266
-
Verwendungszweck
- IL1B Antibody, FITC conjugated
-
Kreuzreaktivität
- Schaf
-
Aufreinigung
- Protein G purified
-
Reinheit
- >95 %
-
Immunogen
- Recombinant Sheep Interleukin-1 beta protein (114-266AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working concentration should be determinde by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClinTM: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- IL-1 beta (IL1B) (Interleukin 1, beta (IL1B))
-
Andere Bezeichnung
- IL1B
-
Hintergrund
-
Background: Produced by activated macrophages, IL-1 stimulates thymocyte proliferation by inducing IL-2 release, B-cell maturation and proliferation, and fibroblast growth factor activity. IL-1 proteins are involved in the inflammat
Aliases: IL1BInterleukin-1 beta antibody, IL-1 beta antibody
-
UniProt
- P21621
-
Pathways
- NF-kappaB Signalweg, Interferon-gamma Pathway, TLR Signalweg, Negative Regulation of Hormone Secretion, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Glycosaminoglycan Metabolic Process, Myometrial Relaxation and Contraction, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Autophagie, Cancer Immune Checkpoints, Inflammasome
Target
-